| Literature DB >> 34691081 |
Alessandro Verde1,2, Maria Mangini1,2, Stefano Managò1, Chiara Tramontano3, Ilaria Rea3, Diana Boraschi2,4,5, Paola Italiani2, Anna Chiara De Luca1,2.
Abstract
Engineered gold nanoparticles (AuNPs) find application in several fields related to human activities (i.e., food and cosmetic industry or water purification) including medicine, where they are employed for diagnosis, drug delivery and cancer therapy. As for any material/reagent for human use, the safety of AuNPs needs accurate evaluation. AuNPs are prone to contamination by bacterial endotoxin (lipopolysaccharide, LPS), a potent elicitor of inflammatory responses in mammals. It is therefore important, when assessing AuNP immunosafety and immune-related effects, to discriminate between inflammatory effects intrinsic to the NPs from those caused by an undeliberate and undetected LPS contamination. Detection of LPS contamination in AuNP preparations poses different problems when using the current LPS detection assays, given the general interference of NPs, similar to other particulate agents, with the assay reagents and endpoints. This leads to time-consuming search for optimal assay conditions for every NP batch, with unpredictable results, and to the use in parallel of different assays, each with its weaknesses and unpredictability. Thus, the development of highly sensitive, quantitative and accurate assays able to detect of LPS on AuNPs is very important, in view of their medical applications. Surface-enhanced Raman spectroscopy (SERS) is a label-free, sensitive, chemical-specific, nondestructive and fast technique that can be used to directly obtain molecular fingerprint information and a quantitative analysis of LPS adsorbed on AuNPs. Within this study, we describe the use of SERS for the label-free identification and quantitative evaluation - down to few attograms - of the LPS adsorbed on the surface of 50 nm AuNPs. We thus propose SERS as an efficient tool to detect LPS on the AuNP surface, and as the basis for the development of a new sensitive and specific LPS-detection sensor based on the use of AuNPs and SERS.Entities:
Keywords: LPS; SERS; biosensor; gold nanoparticles; inflammation; innate immunity
Mesh:
Substances:
Year: 2021 PMID: 34691081 PMCID: PMC8530015 DOI: 10.3389/fimmu.2021.758410
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Morphology analysis of the AuNPs and estimation of the LPS corona. TEM images of bare AuNPs (A) and LPS-coated AuNPs (B). The LPS corona can be observed as a gray halo around AuNPs. Scale bar: 20 nm. (C) Size histograms and Gaussian distribution (black and red lines) related to bare (yellow) and LPS-coated AuNPs (orange). Counts were obtained by measuring the AuNP size in the TEM images. (D) Comparison between hydrodynamic diameters and ζ-potentials of bare (yellow SDs) and LPS-coated AuNPs (orange SDs). Results are reported as mean ± SD of data from 5 independent experiments.
Figure 2DLS analysis and estimation of the LPS corona. Hydrodynamic diameter (A) and ζ-potential (B) of AuNPs incubated with different LPS concentrations. The hydrodynamic diameter of bare AuNPs is 67 ± 5 nm, and their ζ-potential is -32 ± 5 mV (see ). In panel A, hydrodynamic diameter values used for LPS corona estimation on 50 nm AuNPs in saturation condition are highlighted with a green dashed square. Results are reported as mean ± SD of data from 4 independent experiments.
Figure 3LPS-coated AuNPs induce morphological changes in macrophages. (A) Confocal microscopy images showing the morphology of human monocyte-derived macrophages either untreated (CTRL) or exposed to 200 ng/mL free LPS, 1 μg/mL bare AuNPs (AuNPs) and 1 μg/mL LPS-coated AuNPs that contain 200 ng/mL LPS (LPS-AuNPs). The filamentous actin is stained in green, cell nuclei in blue. Scale bar: 10 μm. (B) Quantitative evaluation of cells with an activated phenotype for each treatment. Total cell counts for the 3 independent experiments: 2890 cells in the CTRL sample; 2744 cells in the free LPS sample; 2777 cells in the AUNP sample; 2779 cells in the LPS-AuNP sample. Mean ± SD of data from 3 independent experiments.
Figure 4Macrophage activation by LPS-coated AuNPs. Human monocyte-derived macrophages were treated for 24 h with free LPS (black squares), bare (AuNPs; blue triangles) and LPS-coated AuNPs (AuNPs-LPS; red dots). The production of TNF-α (A), CCL2 (B), IL-1Ra (C) and IL-10 (D) was measured in the culture supernatants by ELISA and normalized as percentage of the maximum value (cytokine levels produced in response to 10 ng/mL LPS). Cytokine concentration ranges were: 0.08-9.40 ng/mL for TNF-α; 0.18-0.38 ng/mL for CCL2; 10.23-78.0 ng/mL for IL-1Ra; 0.28-1.27 ng/mL for IL-10. Results are reported as mean ± SD of data from 3 independent experiments performed on cells from 3 individual donors. *p < 0.01 LPS vs. LPS-AuNPs (Student’s t tests).
Figure 5Raman and SERS spectra of LPS from E. coli and K. pneumoniae. (A) Raman spectrum of LPS powder from E. coli. (B) SERS spectrum of 50 nm AuNPs incubated with 1 mg/mL of LPS from E. coli. (C) SERS spectrum of 50 nm AuNPs incubated with 1 mg/mL of LPS from K. pneumoniae.
Figure 6SERS measurements of the LPS-AuNPs. (A) Variability of raw SERS signals acquired on AuNP clusters related to a single concentration of LPS (1 mg/mL). (B) Average background-corrected SERS signals of AuNPs incubated with different LPS concentrations. LPS concentration (μg/mL) associated to each average SERS spectra are indicated on the right. Every SERS signal is obtained by averaging 30 spectra. (C) 1610 cm-1 peak SERS intensity signal to noise ratio (SNR) as a function of LPS concentration. The blue line represents the theoretical trend for concentration-dependent SERS signals. Green dashed square highlights the linear region of the trend, reported in the panel (D). (D) Linear region of SNR on which LOD was estimated. Means ± SD of 1610 cm-1 peak SNR are reported. The red line represents the linear fit of the experimental data.